GSK3B and type 2 diabetes mellitus: The PI3K/Akt signaling pathway is anti-apoptotic, and AKT1 inhibits Akt phosphorylation (activation), which in turn upregulates the activity of GSK3β, a kinase implicated in the pathogenesis of both T2DM and AD.